Company Profile
BCR Stock Price, News & Analysis
- Ticker:
- BCR
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for BCR.
Company overview
Business overview
C. R. Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson. It represented a durable device and procedure-driven healthcare franchise.
Geographic Base and Sector Classification
Bard was headquartered in the United States and traded on NYSE before the acquisition. Its business was rooted in medical devices rather than biotech or pharma.
Business Model Characteristics
The company generated revenue through procedure-linked products, hospital adoption, and recurring device demand. Investors historically watched product cycles, hospital purchasing, and the stability of its surgical and vascular franchise.
Position Within the Biotechnology Landscape
Bard was outside biotech and closer to the medtech infrastructure layer. Since it was acquired, it is best treated as a historical healthcare infrastructure name.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does BCR do?
C. R. Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson. It represented a durable device and procedure-driven healthcare franchise.
On which exchange is BCR stock listed?
BCR (BCR) is associated with NYSE, United States, Biopharma.
What is Bard?
Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson.
Which conditions is BCR targeting with Bard?
C. R. Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson. It represented a durable device and procedure-driven healthcare franchise.
What is Becton?
Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson.
What is Dickinson?
Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson.